Lung cancer and stroke advocate, foodie, Sailing, Harley Guy, Packers fan. ExecDir serving @LCFAmerica, CEO served NationalStrokeAssoc. Views are my own.
Dr. Ashish Saxena (Weill Cornell) says one question changes outcomes: "Are there clinical trials appropriate for me?"
Only 14% of newly diagnosed patients ask. Timing matters — many trials close once treatment starts.
https://t.co/iqWKu88Ep9
Interesting multi-omic analysis of previously classified SCLC cell lines (YAP1+), identifies that these tumors represent diseases that ‘mimic’ SCLC- in this case- SMARCA4-deficient thoracic tumors, that have a poor prognosis
@CCR_AACR@OncoAlert#LCSM
https://t.co/dOuxMzjU1P
Big pre-snap game for #packers offense - #dallas is gonna do what they do, Love & Co. have to be on the same page and get into the right playcall. #ONMYBLOCK is out previewing round 1!
https://t.co/hF6rHXXKwk
#gopackgo#NFLPlayoffs@BleavNetwork
Dr. Jonathan Villena-Vargas Highlights Collaborative Breakthroughs in Lung Cancer Through a Unified Approach. Learn more about his research in the link below. @JonvillenaM #LungCancer#Research
https://t.co/ir2rYZfnrQ
Meet Dr. Jonathan Villena-Vargas, a surgeon researcher making waves in the world of lung cancer research! His LCFA-funded research focuses on understanding immune responses in early-stage NSCLC. Read more about his research in the link below. @JonvillenaM
https://t.co/ir2rYZfnrQ
🎉Exciting News!🧬🔬 I’m starting a computational biology lab at Memorial Sloan Kettering Cancer Center in NYC! We're hiring at all levels to study how histological transformation and other forms of lineage plasticity drive progression across cancer types! https://t.co/oopDqJVNrZ
Poster presentation went great! Thank you @lcfamerica@Pelotonia@sitcancer for your support of my work!! And thank you @OSUCCC_James@OhioStatePIIO - amazing support as an institution and such a wealth of outstanding colleagues and collaborators!